These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28219368)

  • 41. Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis.
    Dahal A; Bellows BK; Sonpavde G; Tantravahi SK; Choueiri TK; Galsky MD; Agarwal N
    Am J Clin Oncol; 2016 Oct; 39(5):497-506. PubMed ID: 24824144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer.
    Driessen CM; Uijen MJ; van der Graaf WT; van Opstal CC; Kaanders JH; Nijenhuis T; van Herpen CM
    Head Neck; 2016 Apr; 38 Suppl 1():E1575-81. PubMed ID: 26614010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal toxicity and chemotherapy in children with cancer.
    Ruggiero A; Ferrara P; Attinà G; Rizzo D; Riccardi R
    Br J Clin Pharmacol; 2017 Dec; 83(12):2605-2614. PubMed ID: 28758697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
    Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
    Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
    Atasoyu EM; Yildiz S; Bilgi O; Cermik H; Evrenkaya R; Aktas S; Gültepe M; Kandemir EG
    Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma.
    Tiseo M; Martelli O; Mancuso A; Sormani MP; Bruzzi P; Di Salvia R; De Marinis F; Ardizzoni A
    Tumori; 2007; 93(2):138-44. PubMed ID: 17557559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nephrotoxicity: Evidence in Patients Receiving Cisplatin Therapy.
    Duffy EA; Fitzgerald W; Boyle K; Rohatgi R
    Clin J Oncol Nurs; 2018 Apr; 22(2):175-183. PubMed ID: 29547601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity.
    Sahin K; Orhan C; Tuzcu M; Muqbil I; Sahin N; Gencoglu H; Guler O; Padhye SB; Sarkar FH; Mohammad RM
    Biol Trace Elem Res; 2014 Feb; 157(2):156-63. PubMed ID: 24415068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylactic Effect of Premedication with Intravenous Magnesium on Renal Dysfunction in Preoperative Cisplatin-Based Chemotherapy for Esophageal Cancer.
    Kubo Y; Miyata H; Sugimura K; Shinno N; Ushigome H; Yanagimoto Y; Takahashi Y; Yamamoto K; Nishimura J; Wada H; Takahashi H; Yasui M; Omori T; Ohue M; Yano M
    Oncology; 2019; 97(6):319-326. PubMed ID: 31553989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Children's toxicology from bench to bed--Drug-induced renal injury (2): Nephrotoxicity induced by cisplatin and ifosfamide in children.
    Fujieda M; Matsunaga A; Hayashi A; Tauchi H; Chayama K; Sekine T
    J Toxicol Sci; 2009; 34 Suppl 2():SP251-7. PubMed ID: 19571477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients.
    Moon HH; Seo KW; Yoon KY; Shin YM; Choi KH; Lee SH
    World J Gastroenterol; 2011 Aug; 17(30):3510-7. PubMed ID: 21941418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the rates of cisplatin (cDDP)--induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure.
    Leu L; Baribeault D
    J Oncol Pharm Pract; 2010 Sep; 16(3):167-71. PubMed ID: 19759050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The protective effect of theophyline in cisplatin nephrotoxicity.
    Mousavi SS; Zadeh MH; Shahbazian H; Khanzadeh A; Hayati F; Ghorbani A; Golzari K; Valavi E; Motemednia F; Mousavi MB
    Saudi J Kidney Dis Transpl; 2014 Mar; 25(2):333-7. PubMed ID: 24626000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cisplatin nephrotoxicity: experimental and clinical studies.
    Daugaard G
    Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the protective effect of Cystone against cisplatin-induced nephrotoxicity in cancer patients, and its influence on cisplatin antitumor activity.
    El-Ghiaty MA; Ibrahim OM; Abdou SM; Hussein FZ
    Int Urol Nephrol; 2014 Jul; 46(7):1367-73. PubMed ID: 24448757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of oral administration of Arabic gum on cisplatin-induced nephrotoxicity in rats.
    Al-Majed AA; Abd-Allah AR; Al-Rikabi AC; Al-Shabanah OA; Mostafa AM
    J Biochem Mol Toxicol; 2003; 17(3):146-53. PubMed ID: 12815610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between magnesium pre-loading and cisplatin-induced nephrotoxicity in 5-fluorouracil/cisplatin combination therapy for esophageal cancer.
    Sugisaki T; Aoyama T; Kawakami K; Yokokawa T; Kobayashi K; Suzuki W; Ogura M; Ichimura T; Chin K; Yamaguchi K; Hanaoka S; Hayashi H; Yamaguchi M
    Pharmazie; 2022 Feb; 77(2):85-88. PubMed ID: 35209969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery.
    Hakeam HA; Breakiet M; Azzam A; Nadeem A; Amin T
    Ren Fail; 2014 Nov; 36(10):1486-91. PubMed ID: 25155314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.